Glargine Insulin — FDA Animal & Veterinary Adverse Event (ADE) Reports
Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Glargine Insulin is a active ingredient.
Total reports
Glargine Insulin: 20
Reports by species (top entries)
- Cat 17
- Dog 2
- Human 1
Top reported reactions (VEDDRA terms, top entries)
- Death by euthanasia 6
- Decreased appetite 4
- Hyperglycaemia 4
- Hypoglycaemia 3
- Anorexia 2
- Drug prescribing error 2
- Elevated blood urea nitrogen (BUN) 2
- Hypernatremia 2
- Ketonuria 2
- Lethargy (see also Central nervous system depression in Neurological) 2
Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b27.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).